Barnett & Company’s Chemours CC Stock Holding History

Barnett & Company’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-8	Closed	–	–	323
2017 Q2	$0	Hold	8	–	–	﹤0.01%	366
2017 Q1	$0	Hold	8	–	–	﹤0.01%	355
2016 Q4	$0	Hold	8	–	–	﹤0.01%	381
2016 Q3	$0	Hold	8	–	–	﹤0.01%	395
2016 Q2	$0	Hold	8	–	–	﹤0.01%	386
2016 Q1	$0	Buy	+8	New	+$40	﹤0.01%	404

Other funds holding CC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Barnett & Company's CC Position: Q3 2017 in Review

Barnett & Company sold out of Chemours (CC) in Q3 2017, closing a stake of 8 shares.

Barnett & Company first reported a position in CC in Q1 2016 and held it in 6 quarters. The position peaked at $0 in Q2 2017. 500 funds tracked by Wall St. Rank hold CC as of Q3 2017.

Barnett & Company reported no remaining Chemours position as of Q3 2017 after selling out during the quarter.
Barnett & Company sold 8 Chemours shares in Q3 2017.
Barnett & Company first reported a position in Chemours in Q1 2016 and held it in 6 quarters.
Barnett & Company's Chemours position peaked at $0 in Q2 2017.
500 funds tracked by Wall St. Rank held Chemours as of Q3 2017.

Based on Barnett & Company's 13F filing for Q3 2017, filed 20 Nov 2017.